A Mutiple-dose Study of IBI3033 in Healthy Participants

NCT07456839 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Placebo
DRUG: IBI3033

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.